Literature DB >> 22955022

Myositis autoantibodies.

Livia Casciola-Rosen1, Andrew L Mammen.   

Abstract

PURPOSE OF REVIEW: To review recent advances in our understanding of autoantibodies associated with dermatomyositis and the autoimmune necrotizing myopathies. RECENT
FINDINGS: Autoantibodies preferentially associated with dermatomyositis include those recognizing Mi-2, MDA5, TIF1γ, and NXP-2. Each of these is associated with a distinct clinical phenotype. Autoantibodies found in patients with autoimmune necrotizing myopathies recognize signal recognition particle and 3-hydroxy-3-methylglutaryl-coenzime A reductase (HMG-CoA) reductase. The latter are found in patients with statin-associated autoimmune muscle disease.
SUMMARY: As these are helpful both diagnostically and prognostically, a rheumatologist should be familiar with autoantibodies found in patients with dermatomyositis and the autoimmune necrotizing myopathies.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22955022      PMCID： PMC3874450          DOI： 10.1097/BOR.0b013e328358bd85

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN： 1040-8711            Impact factor:   5.006


  46 in total

1.  Mi2, an auto-antigen for dermatomyositis, is an ATP-dependent nucleosome remodeling factor.

Authors:  H B Wang; Y Zhang
Journal:  Nucleic Acids Res       Date:  2001-06-15       Impact factor: 16.971

2.  Antibody to signal recognition particle in polymyositis.

Authors:  I N Targoff; A E Johnson; F W Miller
Journal:  Arthritis Rheum       Date:  1990-09

3.  The dermatomyositis-specific autoantigen Mi2 is a component of a complex containing histone deacetylase and nucleosome remodeling activities.

Authors:  Y Zhang; G LeRoy; H P Seelig; W S Lane; D Reinberg
Journal:  Cell       Date:  1998-10-16       Impact factor: 41.582

4.  Increased frequency of DRB1*11:01 in anti-hydroxymethylglutaryl-coenzyme A reductase-associated autoimmune myopathy.

Authors:  Andrew L Mammen; Daniel Gaudet; Diane Brisson; Lisa Christopher-Stine; Thomas E Lloyd; Mary S Leffell; Andrea A Zachary
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-08       Impact factor: 4.794

5.  Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis.

Authors:  Shinji Sato; Michito Hirakata; Masataka Kuwana; Akira Suwa; Shinichi Inada; Tsuneyo Mimori; Takeji Nishikawa; Chester V Oddis; Yasuo Ikeda
Journal:  Arthritis Rheum       Date:  2005-05

6.  Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositis.

Authors:  Steven A Greenberg; Jack L Pinkus; Geraldine S Pinkus; Travis Burleson; Despina Sanoudou; Rabi Tawil; Richard J Barohn; David S Saperstein; Hannah R Briemberg; Maria Ericsson; Peter Park; Anthony A Amato
Journal:  Ann Neurol       Date:  2005-05       Impact factor: 10.422

7.  Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy.

Authors:  Amy H Kao; David Lacomis; Mary Lucas; Noreen Fertig; Chester V Oddis
Journal:  Arthritis Rheum       Date:  2004-01

8.  A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups.

Authors:  L A Love; R L Leff; D D Fraser; I N Targoff; M Dalakas; P H Plotz; F W Miller
Journal:  Medicine (Baltimore)       Date:  1991-11       Impact factor: 1.889

9.  Human autoantibodies reactive with the signal-recognition particle.

Authors:  W H Reeves; S K Nigam; G Blobel
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

10.  Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy.

Authors:  Livia Casciola-Rosen; Kanneboyina Nagaraju; Paul Plotz; Kondi Wang; Stuart Levine; Edward Gabrielson; Andrea Corse; Antony Rosen
Journal:  J Exp Med       Date:  2005-02-21       Impact factor: 14.307
View more
  43 in total

1.  Statin-induced necrotizing autoimmune myopathy.

Authors:  Syed A Huda; Sanjay Yadava; Sara Kahlown; Muhammad S Farooqi; Stephanie Bryant; Ronald Russo
Journal:  Proc (Bayl Univ Med Cent)       Date:  2020-10-21

2.  Expression of the dermatomyositis autoantigen transcription intermediary factor 1γ in regenerating muscle.

Authors:  Payam Mohassel; Paul Rosen; Livia Casciola-Rosen; Katherine Pak; Andrew L Mammen
Journal:  Arthritis Rheumatol       Date:  2015-01       Impact factor: 10.995

3.  Use of rituximab in histologically confirmed idiopathic inflammatory myositis: a case series.

Authors:  Chaminda Basnayake; Kathy Cash; Peter Blumbergs; Vidya Limaye
Journal:  Clin Rheumatol       Date:  2013-12-13       Impact factor: 2.980

4.  Identification of clinical features and autoantibodies associated with calcinosis in dermatomyositis.

Authors:  Antonia Valenzuela; Lorinda Chung; Livia Casciola-Rosen; David Fiorentino
Journal:  JAMA Dermatol       Date:  2014-07       Impact factor: 10.282

Review 5.  Cutaneous Manifestations in Dermatomyositis: Key Clinical and Serological Features-a Comprehensive Review.

Authors:  Yoshinao Muro; Kazumitsu Sugiura; Masashi Akiyama
Journal:  Clin Rev Allergy Immunol       Date:  2016-12       Impact factor: 8.667

Review 6.  Calcinosis and malignancy are rare in Chinese adult patients with myositis and nuclear matrix protein 2 antibodies identified by an unlabeled immunoprecipitation assay.

Authors:  Li Wang; Li Huang; Yang Yang; Huan Chen; Yanjuan Liu; Ke Liu; Meidong Liu; Yizhi Xiao; Hui Luo; Xiaoxia Zuo; Yisha Li; Xianzhong Xiao; Huali Zhang
Journal:  Clin Rheumatol       Date:  2018-07-23       Impact factor: 2.980

7.  PUF60: a prominent new target of the autoimmune response in dermatomyositis and Sjögren's syndrome.

Authors:  David F Fiorentino; Matthew Presby; Alan N Baer; Michelle Petri; Kerri E Rieger; Mark Soloski; Antony Rosen; Andrew L Mammen; Lisa Christopher-Stine; Livia Casciola-Rosen
Journal:  Ann Rheum Dis       Date:  2015-08-07       Impact factor: 19.103

Review 8.  The NuRD architecture.

Authors:  Hillary F Allen; Paul A Wade; Tatiana G Kutateladze
Journal:  Cell Mol Life Sci       Date:  2013-01-23       Impact factor: 9.261

Review 9.  [Dermatomyositis-update].

Authors:  B Volc-Platzer
Journal:  Hautarzt       Date:  2015-08       Impact factor: 0.751

Review 10.  Cytokines in immune-mediated inflammatory myopathies: cellular sources, multiple actions and therapeutic implications.

Authors:  E M Moran; F L Mastaglia
Journal:  Clin Exp Immunol       Date:  2014-12       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.